Public filings / ELVN on Yahoo Finance (opens in a new tab)
ELVN: insider buying, 13F holders, analyst moves
Enliven Therapeutics Inc - US
A summary of public filings about Enliven Therapeutics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold ELVN
Combined reported value $105.7M.
Holders among our 100 managers: 1 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Samlyn Capital | $46.3M | 0.77% | New |
| Baker Bros. Advisors | $45.9M | 0.23% | Unchanged |
| Deep Track Capital | $11.4M | 0.17% | New |
| Tudor Investment | $2.0M | 0.01% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.